The antiphospholipid antibody syndrome.
Antiphospholipid syndrome includes elevation of either the lupus anticoagulant titer or the anticardiolipin antibody titer on two occasions, separated by 6 weeks in a patient with an episode of thrombosis. The eye is involved frequently in patients with antiphospholipid syndrome. Patients with retinal vascular disease and none of the usual risk factors for retinal vascular disease should be considered at risk for expressing this syndrome.
Bolling
J P
JP
Mayo Clinic, Jacksonville, Florida 32224, USA.
Brown
G C
GC
D017153:Antibodies, Anticardiolipin / Q000276:immunology; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D015415:Biomarkers / Q000097:blood; D005128:Eye Diseases / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000276:immunology; D011379:Prognosis
D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants; D015415:Biomarkers; D016682:Lupus Coagulation Inhibitor